Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: A randomized, double-blinded, placebo-controlled phase 3 trial

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Journal of the American Academy of Dermatology

Topics

Medicine

Immunology

Pathology

Physiology

Dermatology

Show all topics

DOI

10.1016/j.jaad.2020.06.054

License

CC-BY-NC-ND

Other Formats

PDF